Introduction
The progression of cells through the cell cycle is precisely regulated by multiple checkpoints at different transition phases of the cycle [1] [2] [3] [4] [5] . Upon DNA damage, the intra-S-phase checkpoint is activated to ensure the accuracy of DNA replication by suppressing late replication origin activation to allow the DNA damage repair machinery to repair DNA [3] [4] [5] . Activation of the intra-S-phase checkpoint is largely mediated by upstream sensor kinases ATM (ataxia-mutated) and ATR (ataxia-telangiectasia and rad3-related), which are recruited to DNA double strand break or defective replication forks, respectively, where they phosphorylate downstream effector proteins. For example, the activation of ATM phosphorylates γH2AX and NBS1 (Nijmegen breakage syndrome), which forms a protein complex with MRE11 and the RAD50 (MRN) complex [6] [7] [8] [9] [10] . Consistently, both ATM-and NBS1-deficient cells are defective for the intra-S-phase checkpoint [11, 12] . It has been reported that SIRT1 interacts with MRN and deacetylates NBS1, which affects ionizing radiation-induced NBS1 Ser343 phosphorylation [13] , yet the potential impact of SIRT1 on the intra-S-phase checkpoint and DNA replication is largely unknown.
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SIRT1 is a member of the sirtuin family of type III histone deacetylases and plays a role in many biological processes, including cell death and survival, cell proliferation and differentiation, neurological functioning, metabolism, calorie restriction, aging, and cancer [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Using animal models carrying constitutive or tissue-specific loss-of-function mutations of SIRT1, we have previously demonstrated that liver-specific disruption of SIRT1 impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance [20, 24] . Disruption of SIRT1 in the pancreas caused severe pancreas agenesis, characterized by markedly reduced β-cell formation and hyperglycemia [21] .
The potential role of SIRT1 in tumor formation is complex and it may act either as a tumor suppressor or tumor promoter, depending on different tissue contexts and the distribution of SIRT1 downstream targets in specific signaling pathways [25, 26] . Our previous study suggested that expression of the SIRT1 gene is positively regulated by the breast cancer associated gene 1 (BRCA1) and over-expression of SIRT1 in BRCA1-deficient cancer cells inhibited their growth both in vitro and in vivo [27] . Furthermore, about 75% of SIRT1 and p53 double heterozygous (Sirt1 +/-;p53 +/-) mice developed tumors in multiple organs/tissues before 1 year of age [28] . Spectral karyotyping analysis of tumor cells revealed massive changes in chromosomal number and structure. Similar chromosome damage was also observed in Sirt1 -/-embryos during embryonic developmental stages. Thus, it is conceivable that SIRT1 deficiency causes genetic instability, which eventually results in tumorigenesis when some permissive alterations occur, such as inactivation of tumor suppressor genes or activation of oncogenes. However, the exact mechanism by which SIRT1 deficiency causes DNA damage is unclear.
In this study, we investigated the role of SIRT1 in maintaining genome integrity, under base-line conditions and under replicative stress induced by two widely used anticancer drugs, the ribonucleotide reductase inhibitor hydroxyurea (HU) and the topoisomerase inhibitor camptothecin (CPT) [29, 30] . Our data indicate that SIRT1 interacts with multiple proteins that are involved in DNA replication origin firing and replication fork progression. By focusing on one of these proteins, TopBP1, we provide evidence that SIRT1 modulates the intra-S-phase checkpoint and DNA replication origin firing through deacetylating TopBP1.
Materials and Methods

Cell lines
293T cells were obtained from ATCC (Manassas, VA) and cultured with Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen) (Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) (Sigma, St. Louis, MO) and 1% L-glutamine (Invitrogen). MEF cells were obtained from the embryos of wild type and Sirt1 -/-mice as described [28] . Cell transfections were done with X-tremeGENE9 (Roche Applied Science, Indianapolis, IN).
DNA combing assay
Cells were incubated with or without 5 μM camptothecin (CPT) for 4 hours before they were pulse-labeled sequentially with 50 μM iododeoxyuridine (IdU) and 100 μM chlorodeoxyuridine (CldU) (Sigma) for 20 min each. Cells were then harvested for the DNA combing assay as described previously [31] . Images were scanned with an inverted fluorescence microscope using a 40X objective, and recorded using IPLab software (BD Biosciences, Rockville, MD). Fluorescent signals were measured using the ImageJ program (National Cancer Institute) and converted to base-pair values according to the criteria that 1 μm equals 2 kb and 1 pixel encompasses 340 base pairs. Statistical analysis was performed using Prism 5 software (GraphPad).
Preparation and transduction of lentiviral-delivered short-hairpin RNA (shRNA)
For transduction of lentiviral shRNA, pLKO.1 lentiviral vectors targeting SIRT1 were obtained from Sigma. The lentiviral SIRT1 shRNA clone, TRCN0000018979, targets the nucleotide sequence (5'-AAAGCCTTTCTGAATCTAT-3') of SIRT1 mRNA. Lentiviral particles expressing either scrambled or SIRT1 shRNA were produced in 293T cells after 48 hours with the pCMV-dR8.2 dvpr packaging vector and VSV-G envelope vector obtained from Addgene (Cambridge, MA). 293T cells were then transduced with lentiviral particles in the presence of polybrene (8 µg/ml) (Sigma).
Western blotting and Immunoprecipitation
Western blotting was carried out with a Licor (Lincoln, Nebraska) or using the conventional ECL system with antibodies against CHK1 (Cell signaling), CDC7 (Cell Signaling), SIRT1 (Millipore), TopBP1 (Bethyl Lab), PARP (Santa Cruz), Flag antibody (Sigma, M2) and acetyl-lysine (Millipore and Cell Signaling). Immunoprecipitation was carried out as described previously [32] .
DNA synthesis analysis
DNA synthesis analysis was assessed as described [33] . Briefly, cells were cultured in the logarithmic phase and labeled with 10 nCi of 14 C-thymidine (NEN) for 24 hours in DMEM. The medium containing 14 C was then removed and replaced with normal DMEM culture medium for another 24 hours. After the cells were irradiated and incubated accordingly, they were pulse labeled with 3 H-thymidine (NEN) at 2.5 mCi/ml for 15 min. Cells were harvested, washed twice with PBS, and fixed overnight at -20C with 70% ethanol. The samples then were transferred onto Whatman filters and washed with 70% ethanol and 90% methanol sequentially. The dried filters were assayed with a liquid scintillation counter (Beckman, LS6000IC). The resulting ratio of 3 H counts per minute to 14 C counts per minute, corrected for the counts per minute that were the result of channel crossover, was a measure of DNA synthesis.
BrdU incorporation assay
MEF cells were cultured overnight in 10 mm dishes. The cells were then either directly labeled with BrdU (BD), or treated with 10 mM hydroxyurea (HU) for 4 hours and released into medium containing BrdU, or reverse transfected by Lipofectamine TM 2000 (Invitrogen) and then followed with the indicated treatment. The detailed FACS analysis of BrdU-containing samples was performed as described [27] .
Protein pull-down and Mass spectrometry analysis
293T cells were transfected with different amounts of Flag-SIRT1 plasmid (0, 1, 5, 10 µg). Forty-eight hours post transfection, these cells were harvested and lysed. The lysates were immunoprecipitated with an anti-Flag antibody (Sigma, M2) overnight at 4° C. The immuno-complex containing agarose beads were thoroughly washed and the immunoprecipitated beads were used for mass spectrometry analysis as described [21] .
Acetylation assay
Flag-TopBP1 was transfected into 293 cells. Forty-eight hours post transfection; the cells were treated with either 10 mM Nicotinamide or PBS for 14 hours. The cells were then collected and lysed. Flag-TopBP1 was immunoprecipitated by Flag antibody (Sigma, M2) and separated by SDS-PAGE (Invitrogen). The TopBP1 protein band was then in-gel digested with trypsin (Sigma) overnight at 37° C as described [34] . The peptides were extracted following cleavage and lyophilized. The dried peptides were solubilized in 2% acetonitrile, 0.5% acetic acid, 97.5% water. They were trapped on a trapping column and separated on a 75 µm x 15 cm, 2 µm Acclaim PepMap reverse phase column (Thermo Scientific) using an UltiMate 3000 RSLCnano HPLC (Thermo Scientific). Peptides were separated at a flow rate of 300 nL/min followed by online analysis by tandem mass spectrometry using a Thermo Orbitrap Fusion mass spectrometer. Peptides were eluted into the mass spectrometer using a linear gradient from 96% mobile phase A (0.1% formic acid in water) to 55% mobile phase B (20% water, 80% acetonitrile, 0.08% formic acid) over 30 minutes. Parent full-scan mass spectra were collected in the Orbitrap mass analyzer set to acquire data at 120,000 FWHM resolution; ions were then isolated in the quadrupole mass filter, fragmented within the HCD cell (HCD normalized energy 32%, stepped ± 3%), and the product ions were analyzed in the ion trap. The instrument was operated in top-speed mode in which the parental MS spectra were scheduled for collection at least every 3 s, with the embedded control system maximizing the number of MS/MS spectra collected during this period. Monoisotopic precursor selection and dynamic exclusion, with a 30 s duration and 10 ppm mass tolerance, were enabled. Proteome Discoverer 1.4 (Thermo) was used to search the data against human proteins from the UniProt database using SequestHT. The search was limited to tryptic peptides, with maximally two missed cleavages allowed. Cysteine carbamidomethylation was set as a fixed modification; methionine oxidation and lysine acetylation were allowed as variable modifications. The precursor mass tolerance was 10 ppm, and the fragment mass tolerance was 0.6 Da. The Percolator node was used to score and rank peptide matches using a 1% false discovery rate. The spectra for all modified peptides were manually validated.
Chromosome spread
Chromosome spread in MEFs was performed as described [35, 36] . Briefly, the MEF cells were incubated with 100 ng/ml colcemid for 2 hours. The hypotonic treatment was carried out for 20 min at RT in 0.56% KCl. The cells were then transferred to methanol:acetic acid (3:1) for fixation. The fixation was repeated twice. All the chromosome spreads were stained with Giemsa and chromosome number and structure were examined under a 100X lens with a Leica microscope, equipped with a DP72 Olympus camera and CellSense software.
Results
Loss of SIRT1 impairs intra-S-phase checkpoint
Previously we reported that embryos homozygous for a null mutation of SIRT1 (Sirt1 -/-) displayed a higher rate of BrdU incorporation at embryonic day 9.5-14.5 (E10.5-14.5) as compared to control embryos at the same stage, yet the underlying mechanism re-mains elusive [28] . To investigate this, murine embryonic fibroblast cells (MEFs) from SIRT1 wild type (WT) and mutant (MT) embryos at passage 1 or 2 were utilized for BrdU labeling analysis. Under normal culture conditions, higher percentage of SIRT1-MT MEF cells incorporated BrdU compared with SIRT1-WT cells (Fig. 1A) . When these MEF cells were treated with 10 mM hydroxyurea (HU) for 4 hours, and released into medium containing BrdU for 1 hour, SIRT1-MT cells still contained more BrdU positive cells than SIRT1-WT cells (Fig. 1B) . Because similar numbers of SIRT1-WT and MT MEF cells were present at passages 1 and 2 (Fig. 1C) , the increased BrdU incorporation is unlikely to be due to greater cell proliferation, but rather abnormalities associated with DNA replication.
To investigate this, we determined if there is a role for SIRT1 in the intra-S-phase checkpoint by examining primary MEFs in a thymidine incorporation assay to measure DNA replication after γ-radiation. Thirty minutes after γ-radiation exposure ranging from 5 to 20 Gray (Gy), the SIRT1-MT MEFs continued to replicate DNA and even incorporated more thymidine than untreated cells, in contrast to the dose-dependent decline in thymidine incorporation exhibited by the SIRT1-WT MEFs (Fig. 1D) . A time course to assess DNA synthesis demonstrated that SIRT1-MT MEF cells failed to reduce DNA replication within the first 60 min post 10 Gy irradiation, while about a 50% reduction was observed in SIRT1-WT cells (Fig. 1E) . Also, immortalized SIRT1-MT MEFs were more resistant than WT MEFs to inhibition of DNA replication after exposure to the topoisomerase I inhibitor camptothecin (CPT) [29] [37, 38] (Fig. 1F) . Altogether, these data indicate that SIRT1 deficiency results in impaired intra-S-phase checkpoint.
SIRT1 regulates DNA replication fork velocity and origin firing
Next we investigated the potential effect of SIRT1 on DNA replication by using a DNA combing assay. SIRT1-WT and MT-MEFs were first treated with CPT for 1 hour and then pulsed with CldU for the last 20 minutes before changing the media to IdU for the second pulse (Supplementary Material: Figure  S1 ). SIRT1-MT MEF cells displayed significantly reduced fork velocity as compared to wild type cells both in normal culture and replicative stress conditions, indicating a slower DNA synthesis rate in the MT cells ( Fig. 2A) . We also measured inter-origin distances (IODs) in both types of cells. SIRT1-MT cells showed significantly shorter IODs than WT cells, suggesting there is an increase in origin firing in SIRT1-MT cells (Fig. 2B) . These data are consistent with the observed higher thymidine or BrdU incorporation in SIRT1-MT cells compared to WT cells. Further analysis of the rate of DNA synthesis indicated that SIRT1-MT cells displayed uncoordinated DNA replication. The speed of DNA synthesis in WT cells is equal for both right and left arms (Fig.  2C ), but SIRT1-MT cells manifested asymmetric DNA synthesis rates, i.e. in SIRT1-MT cells, right arm synthesis is faster than left arm synthesis (Fig. 2D) . CPT treatment further enhanced asymmetric DNA synthesis in SIRT1-MT cells as compared to WT cells (Fig.  2E, F) . We reasoned that this uncoordinated DNA replication could reflect an accumulation of replication-dependent DNA damage due to the absence of SIRT1.
SIRT1 interacts with proteins associated with DNA replication and intra-S-phase checkpoint regulation
SIRT1 is a well-known histone and protein deacetylase [25, 39] . To identify potential SIRT1 target proteins, we transfected increasing amount of SIRT1 with a Flag epitope into 293T cells followed by mass spectrometric analysis of SIRT1 interacting proteins. We identified 16 proteins that are involved in DNA replication and replication fork protection (Table 1) . Among the list are 4 previously reported SIRT1 deacetylase targets: MCM10 [40] , NBS1 [41] , PARP1 [42] , and p53 [43, 44] ; as well as 12 other interacting proteins that have not been reported previously. This includes components of the replisome, such as CDC7, MCM3, 5, and 7, as well as proteins in the replication protection complex, such as CHK1and TopBP1 [10] . To validate these interactions, 293T cells were transfected with a Flag-SIRT1 construct and then interacting proteins were verified by Flag immunoprecipitation (IP) and Western blot (WB). The results showed that Flag-SIRT1 could interact with both TopBP1 and CDC7 (Fig. 3A, B) .
To further validate the interaction, antibodies for endogenous proteins were used for IP and WB. When endogenous SIRT1 was pulled down, TopBP1, CHK1, and PARP1 were all detected (Fig. 3C) ; at the same time, upon immunoprecipitation of endogenous TopBP1 (Fig. 3D) or CHK1 (Fig. 3E) , SIRT1 was detected as well. Thus, SIRT1, TopBP1, and CHK1 were reciprocally interacting with one another. The interaction among SIRT1, TopBP1, and CHK1 is enhanced in the presence of hydroxyurea (HU) (Fig. 3F) , suggesting that such interactions are enhanced by replication stress.
SIRT1 deacetylates TopBP1 and regulates its activity
Because SIRT1 is a NAD + dependent protein deacetylase, we hypothesized that the identified SIRT1-interacting proteins could be deacetylated by SIRT1. To investigate if this is the case, we first tested whether SIRT1 could deacetylate TopBP1, which plays an essential role in the replication checkpoint response after exposure of cells to replication stress [39, 45] . The results demonstrated that TopBP1 is acetylated and its acetylation level decreased upon ectopic over-expression of wild type SIRT1 (Fig. 4A) . Knocking down SIRT1 by shRNA with lentivirus or over-expressing a SIRT1 deacetylase-defective mutant (SIRT1-HY) enhanced the acetylation of TopBP1 (Fig.  4A) . To identify the potential acetylation sites on TopBP1, we performed in-silico analysis in combination with mass spectrometry analysis. We detected 7 lysine sites within TopBP1 that could be acetylated (K475, K482, K789, K825, K1253, K1398 and K1445) (Fig. 4B , C and Supplementary Material: Figure S2 ). Because of a difficulty to predict which site is important for function of TopBP1, we performed site-directed mutagenesis to generate a TopBP1 expression construct containing three lysine residues mutated to arginine (TopBP1-3R: K475R, K789R and K825R) to mimic the deacetylated form. Comparison of the acetylation state of TopBP1 and TopBP1-3R revealed that these mutations exhibited a reduced acetylation level caused by SIRT1-HY over-expression (Fig. 4D) . To further study the effect of these mutations on DNA replication, we transfected TopBP1-WT, TopBP1-3R (K475R, K789R and K825R), TopBP1-3Q (K475Q, K789Q and K825Q), TopBP1-5R (K475R, K789R, K825R, K1253R, and K1398R) and TopBP1-5Q (K475Q, K789Q, K825Q, K1253Q, and K1398Q), into SIRT1-WT and SIRT1-MT MEF cells and used them in a BrdU incorporation assay. The transfected cells were first treated with HU for 4 hours and then BrdU labeling was performed for 1 hour. As seen in Figure 4E , under all transfection conditions, SIRT1-MT cells exhibited a significantly higher percentage of BrdU + cells than wild type cells, which is consistent with the view that SIRT1 regulates the activity of TopBP1 (Fig. 4E) . In wild type MEF cells, over-expression of the deacetylated forms, TopBP1-3R and TopBP1-5R, significantly reduced the percentage of BrdU positive cells, whereas this effect was not observed when TopBP1-5Q was expressed. Instead, TopBP1-5Q significantly increased the fraction of BrdU incorporating cells in SIRT1-WT cells, mimicking the effect observed in SIRT1-MT MEF cells. Of note, there was minimal effect of these constructs in SIRT1-MT cells, except for TopBP1-5R, which significantly repressed BrdU incorporation. This result is consistent with the view that TopBP1-5R represents the highly activated form of TopBP1 that results from SIRT1 deacetylation.
SIRT1 mutant cells display abnormal DNA replication origin firing and chromosomal damage
Based on these observation, we monitored the progression of replication forks under replication stress after HU treatment. As shown in Figure 5A , in SIRT1-WT MEFs, the majority of the IdU + (red) spots co-localized with the CIdU + (green) spots, indicating HU successfully stalled the replication forks and DNA synthesis restarted from the stalled forks once the replicative stress was removed (Fig. 5A) . In contrast, in HU treated SIRT1-MT cells, fewer IdU + (red) dots and CIdU + (green) dots were co-localized with each other, suggesting that in SIRT1-MT cells, HU was not able to efficiently arrest replication forks (Fig. 5B) . Furthermore, there were many more CIdU + (green) dots in SIRT1-MT cells compared with SIRT1-WT cells, which is consistent with our earlier observation that SIRT1-MT cells contain more active replication foci as compared with SIRT1-WT cells.
Next, we determined whether abnormal replication fork firing could lead to genomic instability by examining the chromosome spread. SIRT1-MT MEF cells displayed a high number of fragmented chromosomes, minute chromosomes, and chromosomes with quadro-crossover, while such abnormalities were minimal in WT cells (Fig. 5C, D) . Altogether, these data uncover an essential role of SIRT1 in maintaining replication fork fidelity and genome stability. 
Discussion
An important finding in the present study is that loss of SIRT1 impairs the intra-S-phase checkpoint, as revealed by a failure to arrest DNA replication under HU or CPT treatment conditions. Our analysis indicates that the effects of SIRT1 on the intra-S-phase checkpoint are, at least in part, mediated by TopBP1. Previous studies have demonstrated that TopBP1 plays a critical role in the control of the DNA replication checkpoint by activating ATR in two different ways. First, TopBP1 can directly interact with and activate ATR through its ATR-activation-domain (AAD) [46] . Second, TopBP1 can increase the binding of ATR to single-stranded DNA (SSD) through increased loading of RPA on SSD [39] . In both cases, activation of TopBP1 enhances ATR-dependent phosphorylation events in response to replication stress, leading to activation of the intra-S-phase checkpoint. The impact of SIRT1 on the intra-S-phase checkpoint might be much more profound, as our data also indicate that SIRT1 interacts with CHK1, which is phosphorylated and activated by ATR, MRE11A and NBS1, which are ATM targets [3] [4] [5] 47] , and p53, which is an upstream regulator of both the ATM and ATR signaling pathways [1, 48, 49] . All these proteins are implicated in the intra-S-phase cell cycle checkpoint [3] [4] [5] [11] [12] [13] . The interaction of SIRT1 with these proteins and its consequences will be further investigated in our future studies.
We also made an intriguing observation that loss of SIRT1 enhances DNA replication origin firing. This could be related to our finding that SIRT1 interacts with three mini-chromosome maintenance proteins (MCM), i.e. MCM3, 5, and 7 that form a hexameric protein complex together with other three MCM proteins: MCM2, 4, and 6 [50] . Together with origin recognition complex proteins (ORC1-6), cell division cycle 6 (CDC6), and chromatin licensing and DNA replication factor 1 (CDT1), the MCM2-7 replicative helicase forms the pre-replication complex (pre-RC), which is required for DNA replication origin firing [50] [51] [52] . Our observation of the interaction of SIRT1 with the MCM2-7 helicase combined with our determination that the loss of SIRT1 caused increased replication origin firing suggests an inhibitory role of SIRT1 in this process. A recent study demonstrated that SIRT1 binds and deacetylates MCM10 and affects DNA replication fork initiation through MCM10 [40] . Thus, SIRT1 could play a role in DNA replication origin firing by regulating both MCM2-7 and MCM10. In addition, SIRT1 also interacts with CDC7 [10] , FEN1 [53] , HBO1 [54] , PARP1 [55] , POLD1 [56] , RECQL4 [57] , and SMC3 [58] , which are involved in various aspects of DNA replication, such as activation, progression, and protection of replication forks. SIRT1 might modulate DNA replication through some of these interacting proteins, although details regarding these interactions remain elusive.
In summary, we have shown that SIRT1-MT cells incorporate more BrdU than control cells under both normal and replicative stress conditions. Further analysis revealed that this is primarily due to the fact that the SIRT1-MT cells contain more active DNA replication origins and fail to arrest DNA synthesis even under replicative stress conditions. By analyzing SIRT1 interacting proteins as revealed by mass spectrometry analysis, we demonstrated that SIRT1 plays an essential role in replication fork firing and intra-S-phase checkpoint through deacetylating and regulating TopBP1. This study provides a molecular basis for the underlying mechanism that SIRT1 deficiency results in genetic instability.
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